14652-14785 IS THE RESISTANCE ZONE
WORLD MARKETS
On Tuesday, Dow fell 0.2%
while S & P 500 and Nasdaq rose 0.3% and 1% respectively, after digesting
March inflation report and news of a halt to the rollout of Johnson &
Johnson vaccine.
U.S. FDA said it’s
recommending a pause in the Johnson & Johnson Covid-19 vaccine after
reported cases of blood clotting.
US consumer price index,
rose 0.6% in March and increased 2.6% from the same period a year ago, slightly
higher than expected figures of 0.5% and 2.5% respectively.
Yesterday, Dow rose 0.2%
while S & P 500 and Nasdaq fell 0.4% and 1% respectively as pressure on
tech offset optimism sparked by the first round of major corporate earnings
that largely exceeded expectations.
Goldman Sachs rose 2%
after blowing past analysts’ expectations with record first-quarter net profits
and revenues. JPMorgan Chase also topped forecasts on the top and bottom lines.
Fed Chair Powell said the
central bank will reduce its monthly bond purchases before it commits to an
interest rate increase.
The yield on the
benchmark 10-year Treasury note rose less than 1 basis point to 1.63%. Spot
gold fell 0.5% to $1,736 per ounce.
Brent crude surged $2.91,
or 4.6%, to $66.58 per barrel while WTI crude futures settled $2.97, or 4.94%,
higher at $63.15 per barrel after a report from the International Energy
Agency, followed by U.S. inventory data boosted optimism about returning demand
for crude. U.S. crude inventories fell by 5.9 million barrels last week,
exceeding forecasts for a 2.9 million-barrel drop. A report from International
Energy Agency predicted global oil demand and supply were set to rebalance in
the second half of the year and added that producers may then need to pump an
additional 2 million bpd to meet the expected demand. The Organization of the
Petroleum Exporting Countries on Tuesday raised its global demand forecast by
70,000 bpd from last month’s forecast and now expects global demand to rise by
5.95 million bpd in 2021.
In Europe, FTSE and CAC
rose 0.7% and 0.4% respectively while DAX fell 0.2%. the European Commission
announced a new deal with Pfizer and BioNTech to deliver 50 million additional
doses of their shot in the second quarter. Euro zone industrial production fell
1% in February from the previous month, as against expectation of a 1.1%
decline.
AT HOME
Benchmark indices surged
1.4% each, recouping nearly 40% of yesterday's mammoth losses. Sensex added 660
points to settle at 48544 while Nifty finished at 14504, up 194 points. Nifty
mid-cap and small-cap indices rose 1.7% and 1.3% respectively. Except 2.6% and
2% lower IT and Teck indices respectively, all the BSE sectoral indices ended
higher, with Auto and Metal indices leading the tally, up 4.3% and 3.5%
respectively.
FIIs net sold stocks worth Rs 731 cr but net bought index
futures and stock futures worth Rs 1995 cr and 1304 cr respectively. DIIs were
net buyers to the tune of Rs 244 cr.
OUTLOOK
Today morning, Nikkei is
up 0.3% while Hang Seng and Shanghai are down 0.5% and 0.8% respectively. SGX
Nifty is trading Around 14650, suggesting around 100 points higher start when
compared to Tuesday's close of Nifty futures.
In Tuesday's report we
had said that 14248, the low made Monday, coincided with the downward sloping
trnedline adjoining bottoms made on 26th February and 19th March and also
roughly coincided with the 14264 bottom made in March making it an immediate
support. We had also said that 14652-14785, the gap created by Monday's
gap-down opening, would act as the resistance zone.
Nifty surged to touch a
high of 14529 before closing at 14504. The benchmark is set to open near 14600
today.
14652-14785, the gap
created by Monday's gap-down opening, continues to be resistance zone to eye.
14248, the bottom made
Monday, continues to be important immediate support.
No comments:
Post a Comment